CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lanzhou Foci Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lanzhou Foci Pharmaceutical Co Ltd
No.2289 Huashan Road, Lanzhou New Area
Phone: +86 9318362318p:+86 9318362318 LANZHOU, GNS  730000  China Ticker: 002644002644
Business Summary
Lanzhou Foci Pharmaceutical Co Ltd is a China-based company mainly engaged in the manufacture of traditional Chinese medicine. The Company's main businesses include the research and development, production and sales of Chinese patent medicines and health products, cultivation and sales of Chinese medicinal materials, processing and sales of Chinese herbal medicines, production and sales of medical devices such as protective masks, and others. The Company's products include Fufang Huangqi Jianpi Oral Liquid, Liuwei Dihuang Pills, Xiaoyao Pills, Xiangsha Yangwei Pills, Shenrong Guben Huanshao Pills, donkey-hide gelatin, Chinese herbal medicine slices, and others. The Company's products cover categories and fields such as tonic, cold, gastrointestinal, gynecology, and tranquilizing sleep.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board XiaodongShan 47 4/30/2024 4/30/2024
Chief Financial Officer JinfengYue 45 11/30/2022 11/30/2022
Acting General Manager, Executive Deputy General Manager, Director ShuangxiQian 39 8/14/2024 8/14/2024
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,353 (As of 12/31/2023)
Outstanding Shares: 510,657,000 (As of 9/30/2024)
Shareholders: 28,378
Stock Exchange: SHE
Fax Number: +86 9318362318


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, January 28, 2025